Pediatric idiopathic intracranial hypertension and extreme childhood obesity.
Sonu M Brara, Corinna Koebnick, Amy H Porter...
https://pubmed.ncbi.nlm.nih.gov/22633290/Actively Recruiting
Led by University of Valencia · Updated on 2026-04-22
25
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to explore the relationship between body mass index BMI changes and treatment response in people with Idiopathic Intracranial Hypertension IIH. The study seeks to determine the BMI level at which IIH occurs, how much BMI needs to be lowered to resolve the condition, and how patients who do not lose weight or continue gaining weight respond to treatments such as Acetazolamide or cerebrospinal fluid CSF diversion procedures. It addresses the challenges patients face with weight loss and the complications linked to treatment failures and shunt system malfunctions. Participants will be observed without receiving medication to assist weight loss. Their weight will be recorded every three months and correlated with their response to treatments like weight loss alone, diuretic drugs Acetazolamide, or surgical CSF diversion methods including lumboperitoneal or ventriculoperitoneal shunts. Bariatric surgery and endocrinology-recommended diets may be part of patient care, but weight loss medication is not used or approved in this study. During the study, participants will have their weight tracked regularly for about one year to assess how they respond to the various treatments. Researchers will measure treatment response over this period to understand the impact of BMI changes on IIH. The study does not provide treatments but observes existing approaches and their outcomes. The goal is to establish clearer BMI targets to help patients manage the disease effectively.
CONDITIONS
BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment
V
Vicente Vanaclocha, Professor
T
Teresa Moratal, Secretary
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Valencia
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Approximately 1 year
Participants with Idiopathic Intracranial Hypertension have their weight recorded every three months to assess response to different treatment modalities without additional medication for weight loss.
Quarterly visits every 3 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Sonu M Brara, Corinna Koebnick, Amy H Porter...
https://pubmed.ncbi.nlm.nih.gov/22633290/Susan P Mollan, James L Mitchell, Ryan S Ottridge...
https://pubmed.ncbi.nlm.nih.gov/33900360/J J Kleinschmidt, K B Digre, R Hanover
https://pubmed.ncbi.nlm.nih.gov/10668690/Marina Ybarra, Tiago Jeronimo Dos Santos, Edjane Santos Queiroz...
https://pubmed.ncbi.nlm.nih.gov/31939513/Khin P Kilgore, Michael S Lee, Jacqueline A Leavitt...
https://pubmed.ncbi.nlm.nih.gov/28187976/Magda Aguiar, Emma Frew, Susan P Mollan...
https://pubmed.ncbi.nlm.nih.gov/33946177/Daniele L Greener, Danyal Akarca, Andrew J Durnford...
https://pubmed.ncbi.nlm.nih.gov/31954904/Jan Hoffmann, Susan P Mollan, Koen Paemeleire...
https://pubmed.ncbi.nlm.nih.gov/30298346/M Wall, W M Hart, R M Burde
https://pubmed.ncbi.nlm.nih.gov/6638133/M J Kupersmith, L Gamell, R Turbin...
https://pubmed.ncbi.nlm.nih.gov/9566400/University of Valencia
Lead Sponsor